article thumbnail

VR roundup: FDA clears new device for pain, Stanford says immersive therapeutics can help seniors

Healthcare It News

Previously, on September 25, FDA cleared the VR system for the drug-free, temporary relief of acute anxiety associated with needle procedures, Smileyscope said. The company holds a patent for Procedural Choreography, a proprietary technique that reframes real-world stimuli with positive virtual stimuli.

FDA 228
article thumbnail

The FDA Ramps Up GMP Inspections

Dot Compliance

Prior to the COVID-19 pandemic, during fiscal year (FY) 2019 (October 1, 2018, through September 30, 2019), the FDA conducted 7,266 GMP inspections of registered drug, device and biologics establishments. Compliance Dashboard, Inspections, FDA, accessed October 3, 2022, [link] cd/inspections.htm ).

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Public Health Product Hops

Bill of Health

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. My talk was titled “Legal Approaches to Ensuring Timely Generic Drug Availability.”

article thumbnail

The Caveats of CES 2019

Health Populi

Federal government shutdown. There was a lot of Twitter activity in my tweet-feed about an Amazon Alexa-enabled toilets at CES 2019. Descriptions waxed lyrically about it, such as a, “fully-immersive experience,” “Game of Thrones,” and, “CES 2019 is flush with smart toilets.”

FDA 87
article thumbnail

California Enters Insulin Manufacturing: Can We Expect to See a California Effect?

Bill of Health

have debated whether the government should produce drugs and biologics. Ultimately, the industry was successful in keeping the government away from biologics manufacturing by agreeing to abide by government regulations. Once approved by the FDA, CalRx insulin will be made available at $30 to all Californians who need it.

article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. public investment in the development of mRNA COVID-19 vaccines between 1985 to 2019.

article thumbnail

Microdosing at Work: Business and Legal Implications

Bill of Health

A 2019 analysis of a Reddit discussion group devoted to microdosing recorded 27,000 subscribers; as of April 1, 2022, the number had ballooned to 194,000. To be sure, many private sector employers are constrained with respect to workforce policy discretion, whether for reasons arising from safety, insurance or government contract status.

Licensing 293